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Summary To determine the cause of the increased content of carbohydrate-bound phosphate in tumour
lysosomal hydrolases, the activity and kinetics in human hepatocellular carcinoma of two enzymes involved in
the formation of mannose-6-phosphate in lysosomal hydrolases UDP-GlcNAc: lysosomal enzyme GlcNAca
1-phosphotransferase (GlcNAc-phosphotransferase) and phosphodiester glycosidase were studied. The activity
level of the phosphotransferase with artificial and natural substrates was elevated (P<0.025 and P<0.001,
respectively) in hepatoma compared to that in uninvolved tissue, while the phosphodiester glycosidase of
hepatoma was at a level similar to that of the uninvolved tissue.
To verify a previous observation that cathepsin D of human hepatoma contained increased GlcNAc-
phosphomannose, the protease was examined for carbohydrate phosphorylation by the GlcNAc-phospho-
transferase. The protease from normal human liver was much more phosphorylated than hepatoma protease,
confirming the previous observation. The predominant phosphorylation of the protease occurred in one of two
major heavy subunits, with some phosphorylation in one of two minor light subunits.
It has been demonstrated that lysosomal hydrolases from
tumour sources often generate single or multiple acidic
variant forms which are more negatively charged than the
ordinary forms (Motomiya et al., 1975; Wasserman & Aus-
ten, 1977; Ellis et al., 1978; Dewji et al., 1981). Studies from
this laboratory have demonstrated that arysulfatase A (Nak-
amura et al., 1984) and arysulfatase B (Gasa et al., 1981;
Gasa & Makita, 1983; Uehara et al., 1983), P-glucuronidase
(Fujita et al., 1984), and cathepsin D (Maguchi et al., 1988)
from human cancers are modified with increased phos-
phorylation at their carbohydrate moieties.
The lysosomal hydrolases undergo post-translational pro-
cessing at protein and carbohydrate moieties coupled with
targeting to lysosomes via the Golgi apparatus (reviewed in
Sly & Fisher, 1982; Kornfeld & Kornfeld, 1985; von Figura
& Hasilik, 1986). Mannose-6-phosphate residues at high-
mannose oligosaccharide chains formed in the processing of
the carbohydrates act as a recognition marker for the tar-
geting. Phosphorylated mannose is formed through two
enzymes present in Golgi membranes, GIcNAc-phospho-
transferase, which transfers N-acetylglucosamine-l-phosphate
from UDP-GlcNAc to mannose residues at non-reducing
termini, giving mannose-6-phosphate-lah-N -acetylglucosa-
mine (Man-P-GlcNAc), and phosphodiester a-N -acetylglu-
cosaminidase, which converts Man-P-GlcNAc to mannose-6-
phosphate. However, few studies (Uehara et al., 1989) have
been carried out on tumour-associated phosphorylation reac-
tions at hydrolase carbohydrates. The present study demon-
strates that the increased generation of mannose-6-phosphate
in tumour hydrolases is brought about by an elevated level of
phosphotransferase. Furthermore, phosphotransferase was
investigated for phosphorylation of cathepsin D, a physio-
logical substrate of the enzyme.
Materials and methods
Chemicals
a- Methylmannoside, N-acetylglucosamine, UDP-GlcNAc
and N-acetylmannosamine were obtained from Sigma (USA).
QAE-Sephadex A-25 was purchased from Pharmacia LKB
(Sweden). Endo-p-N-acetylhexosaminidase H (endo-H) was
from Seikagaku Kogyo (Japan). [P-32P]UDP-GlcNAc was
prepared according to the method described by Lang and
Kornfeld (1984). [6-3H]GlcNAc-P-6-(x-methyl) mannoside
was synthesised by the method of Varki and Kornfeld (1981).
Other reagents were of analytical grade.
Human liver tissues
Hepatocellular carcinoma tissues were obtained at autopsy
and separated into involved and uninvolved portions. Meta-
static liver tumours from gall bladder adenocarcinoma and
extrahepatic biliary duct adenocarcinoma, liver cirrhosis tis-
sues, and liver free from pathological changes were obtained
at autopsy. All the tissues were obtained within 5 h after
death, characterised histopathologically and stored at - 80°C
until use.
Enzymepreparation
Approximately 1 g of the tissue was homogenised with a
Polytron homogeniser in 3 volumes of 50 mM Tris-HCI
buffer, pH 7.5, 0.5 M sucrose, 5 mM MgCI2 and centrifuged at
600 g for O min. The supernatant was employed for assays
of the two processing enzymes. In all experiments, duplicate
determination was done. Human cathepsin D was purified
from normal liver and hepatoma according to the method
described previously (Maguchi et al., 1988). GlcNAc-phos-
photransferase was partially purified from rat liver as
described previously (Reitman et al., 1984). Protein was
determined by the method of Lowry et al. (1951) with bovine
serum albumin as the standard.
Assay ofGlcNAc-phosphotransferase activity
All the enzyme activities were assayed in duplicate. This was
carried out as described previously (Reitman et al., 1984)
with some modifications. The reaction mixture of 50jld con-
tained 150 JIM [_-32P]UDP-GlcNAc (67 c.p.m. pmol-1), 200
mM a-methylmannoside, 5 mM ATP, 50 mM N-acetylglucos-
amine, 10 mM MnC12, 1OmM MgCl2, 250 LM dithiothreitol,
10 mM sodium molybdate, 2 mg ml-' of bovine serum albu-
min, 1% Lubrol PX, 50 mM Tris-HCI buffer, pH 7.4, and
enzyme unless otherwise stated. After incubation at 37°C for
30 min, the reaction was terminated by adding 1 ml of 5 mM
sodium EDTA, pH 7.8. The mixture was applied directly to a
QAE-Sephadex column (1 ml) which had been equilibrated
with 2 mM Tris-HCI buffer, pH 8.0 (buffer A). After washing
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the column with 2 ml of buffer A, the reaction product,
labelled GIcNAc-P-6-(a-methyl)mannoside, was selectively
eluted by 4ml of buffer A containing 30mM NaCl. The
eluate was assayed for radioactivity after the addition of a
12 ml scintillation cocktail. One unit (U) of the enzyme
activity was defined as the amount producing one pmol of
the product per hour. As a control experiment, the reaction
mixture to which EDTA had been added prior to incubation
was used.
When purified human cathepsin D was used as the sub-
strate, the method described above was modified as follows.
The reaction mixture contained cathepsin D, 100 yM [P-
32P]UDP-GIcNAc (100 c.p.m. pmolh'), the above cofactors
and partially purified GlcNAc-phosphotransferase or tissue
homogenates in a final volume of 501l. After incubation at
37°C for 1 h, the reaction was terminated by the addition of
unlabelled UDP-GlcNAc followed by acid precipitation with
20% trichloroacetic acid. The precipitate was washed with
0.1 M Tris-HCI, pH 8.0, 0.1 M sodium glycerophosphate,
50 mM N-acetylglucosamine and 20 mM CaCI2, and incu-
bated in 1 ml of the above buffer containing 4 mg of pronase
at 56°C for 30 min. The resultant solution was applied to a
concanavalin A-Sepharose column (1 ml). After washing the
column with phosphate-buffered saline, the resin was ex-
truded into a scintillation vial for measurement of radioac-
tivity. The control experiment for the activity was the same
as described above. The technical error was less than 5%
between duplicate experiments by this method, indicating
high reproducibility.
For autoradiography of phosphorylated cathepsin D, the
acid-precipitate was subjected to electrophoresis using poly-
acrylamide slab gel (15%) containing 0.1% SDS (SDS-
PAGE) as described by Laemmli (1970). The gel was dried
and exposed to X-ray film (Fuji-RX) for 7 days at -80°C.
to 800pg with 30min-incubation. The Km values of the
transferase for a-methylmannoside (50 to 100 mM in normal
liver, and 70 to 130 mM in hepatoma) were much higher than
those for UDP-GlcNAc (27 to 37pM in liver and 30 to
33liM in hepatoma). Essentially, no differences were found
between the Km values of normal liver and hepatoma when
three enzyme preparations of different tissues from normal
liver and hepatoma were examined.
The reactions of the phosphodiester glycosidase of the
normal liver and hepatoma proceeded linearly with the reac-
tion time until 4 h with up to 500pg of protein (data not
shown). The amount of the labelled substrate used for the
glycosidase assay was not sufficient to measure Km values.
Activity levels ofthe twoprocessing enzymes in hepatoma
The overall activity level of GIcNAc-phosphotransferase
using a-methylmannoside was elevated in hepatoma (mean
± s.d., 185 ± 103 U mg-' protein, n = 15) as compared to
that in normal liver (118 ± 40, n = 13; P<0.025, Student's
t-test). However, a marked elevation of the activity above
that of normal liver was observed in 33% of the hepatoma
cases examined, as shown in Figure 1. Metastatic liver
tumours showed higher transferase activity (222 and 298
Umg-'), whereas the activity (108, 130 and 145 Umg-') in
liver cirrhosis was at a level similar to that of normal liver.
When individual hepatomas in which both involved and
uninvolved tissues were available from the same patients
were assayed for phosphotransferase, the activity was higher
in five out of eight hepatomas as compared to that in unin-
volved tissue. On the other hand, no significant difference of
phosphodiester glycosidase activity was found between hepa-
toma (9.71 ± 6.5%, n = 11) and normal liver (6.25 ± 2.1%,
n= 13).
Assay ofphosphodiester glycosidase activity
The assay was carried out as described previously by Ben-
Yoseph et al. (1984) with some modifications. Aliquots of
[3H]GlcNAcl-P-6 (a-methyl)mannoside (5,000 d.p.m.) were
put into a test tube and the solvent was removed using a
centrifuge evaporator. To the tube were added 50 mM Tris-
HCI buffer, pH 7.4, 0.5% Triton X-100, 10 mM N-acetyl-
mannosamine, 5 mM sodium EDTA and enzyme in a final
volume of 50 gl. After incubation at 37°C for 4 h, the reac-
tion was terminated in a boiling water bath for 5 min. The
mixture was supplemented with 1 ml ofbuffer A, and applied
to a QAE-Sephadex column (1 ml) equilibrated with buffer
A. After washing the column with 3 ml of buffer A, a 4 ml
flow-through fraction that contained liberated, labelled N-
acetylglucosamine was measured for radioactivity in a 12 ml
scintillation cocktail. Incubation mixture without incubation
was processed as a blank. The activity of the glycosidase was
expressed by the percentage of N-acetylglucosamine released
from the total amount of the substrate added per hour.
Endo-P-N-acetylhexosaminidase H treatment ofcathepsin D
Cathepsin D purified from normal human liver was treated
with 50 mU of endo-H in 0.1M citrate-phosphate buffer,
pH 4.5, in a final volume of 50pl at 37°C for 16 h. The
mixture was supplemented with 10ftl of a sample buffer for
SDS-PAGE, heated at 100C for 5 min and subjected to
SDS-PAGE (15% gel). The gel was stained with Coomassie
Brilliant Blue.
Results
Reactions ofthe two processing enzymes
The activity ofGlcNAc-phosphotransferase toward a-methyl-
mannoside in normal liver and hepatoma increased linearly
depending on the reaction time until 1 h when using approx-
imately 500 sg of each homogenate, and protein amounts up
Phosphorylation ofcathepsin D
When GlcNAc-phosphotransferase activity was assayed with
cathepsin D, a physiological substrate, elevation of the activ-
ity in the hepatoma transferase was much clearer (P<0.001)
than with oc-methylmannoside (Table I), although a much
lower concentration of the protease was used. Figure 2 shows
the increased incorporation of phosphate into the protease
substrate by the hepatoma phosphotransferase. To compare
phosphate incorporation into purified cathepsin D from nor-
mal liver and hepatoma, the two protease preparations were
p < 0.025
L
NL HCC
Figure 1 GlcNAc-phosphotransferase activity in human liver
tissues. The activity was assayed for GlcNAc-phosphotransferase
using a-methylmannoside as the substrate. NL, normal liver;
HCC, hepatocellular carcinoma.GlcNAc-PHOSPHOTRANSFERASE IN HEPATOMA 907
Table I GIcNAc-phosphotransferase activity of normal liver and
hepatoma toward normal liver cathepsin D
Number of GlcNAc-phosphotransferase
Tissues cases activity (Umg-' proteina)
Normal liver 5 0.74 ± 0.37b,c
Hepatoma 5 8.62 ± 1.79b
'Theconcentration ofcathepsin Dfortheassaywas 12 ,M.bStudent's
t-test, P<0.001. cMean ± s.d.
2 3
66.2 K-
42.7 K-
31.0 K
21.5 K-
14.4 K
Figure 2 Autoradiogram ofcathepsin D phosphorylated by nor-
mal liver and hepatoma homogenates. Cathepsin D (10gsg)
purified from normal human liver was incubated with 444gg of
hepatoma protein or 8931ig of liver protein, 5 x I05 c.p.m. [P-
32P]UDP-GlcNAc and cofactors for 2 h, acid-precipitated, elec-
trophoresed in the presence of SDS and autoradiographed as
described in Materials and methods. Lane 1, hepatoma; lane 2,
normal liver; lane 3, hepatoma in the absence of cathepsin D
(control).
Table II Phosphorylation of cathepsin D by partially purified
GIcNAc-phosphotransferase'
Cathepsin D Amount Phosphate incorporation
from (1tgprotein) (pmolh-')
Normal liver 25 3.9
17 1.6
Hepatoma 28 0.9
17 0.4
'The amount ofGlcNAc-phosphotransferase was 104 U.
.1 2 3 --
974K I
42.1K-
31.0 K-
21.5K.
14.4 K1-.
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Figure 3 Deglycosylation and GIcNAc-phosphorylation of cath-
epsin D purified from normal human liver. Cathepsin D purified
from normal liver was electrophoresed before (lane 1, 10fig of
the protease was used) and after (lane 2, 5gtg) treatment with
endo-p-acetylglucosaminidase H followed by staining with Coo-
massie Brilliant Blue. The band at 66.2 kDa is a protein included
in the endoglycosidase preparation. Cathepsin D (10gsg) was also
incubated with partially purified GlcNAc-phosphotransferase
(104 U toward a-methylmannoside) from rat liver, LP-32P]UDP-
GlcNAc (1 x 106 c.p.m.) and cofactors for 2 h, acid-precipitated
and electrophoresed in the presence of SDS followed by auto-
radiography as described under Materials and methods.
subjected to the reaction using partially purified GlcNAc-
phosphotransferase from rat liver. As shown in Table II,
more normal liver protease was phosphorylated than hepa-
toma protease. Cathepsin D of normal liver was composed of
a minor 42 kDa chain, two heavy chains (31 kDa and
29 kDa) and two minor light chains (15 kDa and 14 kDa) on
SDS-PAGE (Figure 3). We then examined which components
of the protease were phosphorylated. As shown in Figure 3,
the major heavy chains were remarkably phosphorylated,
while the 15 kDa light chain was only slightly phosphory-
lated.
Since multiple components of the protease can be ex-
plained by the difference ofcarbohydrate chains, the effect of
deglycosylation in the protease components was examined.
Upon treatment with endo-p-N-acetylglucoasminidase H, the
31 kDa and 15 kDa chains became invisible, possibly being
converted into 29 kDa and 13 kDa chains, respectively.
Therefore, the major 31 kDa and the minor 15 kDa chains
must possess high-mannose oligosaccharide chains, which are
substrates for GlcNAc-phosphotransferase.
Discussion
In previous studies on human cancers, we demonstrated that
many lysosomal enzymes, arylsulfatase A (Nakamura et al.,
1984) and arylsulfatase B (Gasa et al., 1980), P-glucuronidase
(Fujita et al., 1984) and P-N-acetylhexosaminidase B (Narita
et al., 1983) from lung cancer, arysulfatase B in chronic
myelogenous leukemic cells (Uehara et al., 1983) and cathep-
sin D in hepatocellular carcinoma (Maguchi et al., 1988)
generate heterogenous acidic variant forms that are not
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detectable or are only present in minute amounts in normal
tissue in addition to their ordinary forms. Treatment of these
tumour lysosomal hydrolases with alkaline phosphatase
brought about marked reduction of the acidic variants, but
some of the variants remained unchanged, suggesting the
presence of phosphodiester residues. Treatment with endo-H
converted most acidic variants to the respective ordinary
forms of the hydrolases. In the present study on two enzymes
involved in processing at carbohydrates of lysosomal hydro-
lases, the activity of GlcNAc-phosphotransferase toward
cathepsin D and methylmannoside was increased in human
hepatoma, while no significant change in phosphodiester
glycosidase was observed. Using cathepsin D from normal
liver as a native substrate, the elevation of hepatoma phos-
photransferase was more clearly demonstrated. On the other
hand, hepatoma protease was a poor substrate for phospho-
transferase. These observations suggest that mannosyl resi-
dues available for phosphorylation in hepatoma protease are
more saturated with phosphates than those in the normal
liver protease, confirming the previous observation that the
hepatoma protease contained more mannose-6-phosphate
(Maguchi et al., 1988). Elevated activity of phosphotrans-
ferase, but not of phosphodiester glycosidase, was also
observed in human chronic myelogenous leukaemic cells
(Uehara et al., 1989). Therefore, the elevation of transferase
activity appears to be associated with many types of human
cancer and to bring about increased formation of the man-
nosyl phosphomono- and diesters responsible for the forma-
tion of acidic variants of tumour hydrolases.
In cathepsin D ofporcine spleen, high-mannose-type oligo-
saccharides were demonstrated to be the major saccharides in
the heavy subunit and the only ones in the light subunit
(Takahashi et al., 1983). In the present study, the heavy and
light chains of human liver cathepsin D were resolved on
SDS-PAGE into upper and lower bands, respectively, prob-
ably based on differences in constituent carbohydrate chains
whose structures are not known. The 31 kDa and 15 kDa
upper bands were targets for GlcNAc-phosphotransferase
and susceptible to endo-,-N-acetylglucosaminidase H (Figure
3). Judging from the data, the lower bands (29 kDa and
14 kDa) may contain carbohydrates that have been already
phosphorylated and/or are composed ofcomplex-type chains.
The authors are indebted to Ms Utae Hatakeyama for her help with
this manuscript. This work was supported by a Grant-in-Aid from
the Ministry of Education, Science and Culture, Japan.
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